πŸ‡ΊπŸ‡Έ FDA
Patent

US 9751885

Cyclopropanamine compound and use thereof

granted A61KA61K45/06A61P

Quick answer

US patent 9751885 (Cyclopropanamine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K45/06, A61P, A61P25/14, A61P25/16